U.S. Senator James Lankford, R-OK, wants CVS to answer for its decision to push its own generic medication rather than allowing customers to also access other low-cost prescription drugs.
The test will help healthcare providers to assess an individual's risk of developing opioid use disorder, offering a new approach to pain management.